Clinical trials: Spinal Injections

Ankylosing Spondylitis

Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis

• Completed
• Age: 18 years and older
• Phase 3
• Results posted

The purpose of this study is to evaluate the safety and efficacy of golimumab in Chinese patients with ankylosing spondylitis

Trial name

NCT01248793

Testing

Golimumab

Where

7 sites in China

Volunteers

213 people

Sponsor

Centocor, Inc.